Humira vs Cosentyx
Adalimumab vs Secukinumab · Comparison Guide
Quick Comparison
| Feature | Humira | Cosentyx |
|---|---|---|
| Generic Name | Adalimumab | Secukinumab |
| Manufacturer | AbbVie | Novartis |
| Drug Class | TNF-alpha Inhibitor | IL-17A Inhibitor |
| Shared Conditions | Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis | |
Key Differences: Humira vs Cosentyx
Cosentyx and Humira are both approved for psoriasis, PsA, and AS. For psoriasis, IL-17A inhibitors like Cosentyx generally show faster and higher clearance rates than TNF inhibitors. For AS, both are highly effective first-line options. Cosentyx should be used with caution in patients with IBD as IL-17 inhibition can worsen inflammatory bowel disease.
💊 Humira (Adalimumab)
- Class: TNF-alpha Inhibitor
- Manufacturer: AbbVie
- Full Humira information →
💊 Cosentyx (Secukinumab)
- Class: IL-17A Inhibitor
- Manufacturer: Novartis
- Full Cosentyx information →
Cosentyx and Humira are both approved for psoriasis, PsA, and AS. For psoriasis, IL-17A inhibitors like Cosentyx generally show faster and higher clearance rates than TNF inhibitors. For AS, both are highly effective first-line options. Cosentyx should be used with caution in patients with IBD as IL-17 inhibition can worsen inflammatory bowel disease.
Neither Humira nor Cosentyx is universally better — the right choice depends on your specific condition, disease severity, insurance formulary, and health history. Your prescriber will determine which is most appropriate based on your clinical situation. BiologicHealthPlus carries both and can help you compare your coverage and costs for either medication.
Switching between biologics is common. Your prescriber will evaluate your current treatment response and determine if a switch is appropriate. BiologicHealthPlus can coordinate the transition including prior authorization for your new medication.
Both Humira and Cosentyx are covered by most commercial insurance plans, Medicare Part D, and Medicaid with prior authorization. BiologicHealthPlus handles insurance verification and prior authorization for both medications at no charge. Most insured patients pay $0–$35/month through manufacturer copay programs.
Humira and Cosentyx both have high cash list prices ($4,000–$9,000/month range) but most commercially insured patients pay $0–$35/month through manufacturer savings programs. BiologicHealthPlus automatically enrolls every patient in all available savings programs at no charge.
✅ BiologicHealthPlus Carries Both Humira and Cosentyx
We handle insurance verification, prior authorization, copay enrollment, and free cold-chain delivery for both medications. Contact us and we'll help you understand your options and costs.
Medical Disclaimer: This comparison is for educational purposes only. The choice between Humira and Cosentyx should be made by your healthcare provider based on your specific medical history, disease severity, and individual circumstances. Last updated: July 2026.